Antibacterial Properties of Senecio sandrasicus. on Multidrug-Resistant Stenotrophomonas maltophilia.

References

• Babalova M, Blahova J, Lesicka-Hupkova M, Kremery Sr.V, Kubonova K (1995): Transfer of ceftazidime and aztreonam resistance from nososcomial strains of Xanthomonas. (Stenotrophomonas.) maltophilia. to a recipient strain of Pseudomonas aeruginosa. ML-1008. Eur J Clin Microbiol Infect Dis 14: 925–927. [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Bauer AW, Kirby MM, Sherris JL, Turck M (1966): Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol 45: 493–496. [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Bush K, Jacoby GA, Medeiros AA (1995): A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother 39: 1211–1233. [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Collins CH, Lyne PM, Grange JM (1995): Microbiological Methods, 7th ed. London, Butterworths, pp. 493.
   Google Scholar
• Cullmann W (1991): Antibiotic susceptibility and outer membrane proteins of clinical Xanthomonas maltophilia. isolates. Chemotherapy (Basel). 37: 246–250. [CSA]
   PubMedGoogle Scholar
• Davis PH (1975): Flora of Turkey and the East Aegean Islands, Vol. 5. Edinburgh, University Press.
   Google Scholar
• Denton M, Kerr KG (1998): Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia.. Clin Microbiol Rev 11: 57–80. [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Denny BJ, Lambert PA, West PWJ (2002): The flavonoid galangin inhibits the L1 metallo-β-lactamase from Stenotrophomonas maltophilia.. FEMS Microbiol Lett 208: 21–24. [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• El-Shazly A, Doral G, Wink M (2002): Chemical composition and biological activity of the essential oils of Senecio aegyptius. var. discoideus. Boiss. Z Naturforsch 57c: 434–439. [CSA]
   Google Scholar
• Felegie TP, Yu VL, Rumans LW, Yee RB (1979): Susceptibility of Pseudomonas maltophilia. to antimicrobial agents, singly and in combination. Antimicrob Agents Chemother 16: 833–837. [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Fisher MC, Long SS, Roberts EM, Dun JM, Babara RK (1981): Pseudomonas maltophilia. bacteremia in children undergoing open heart surgery. JAMA 246: 1471–1474. [CROSSREF], [CSA]
   Google Scholar
• Fluit AC, Verhoef FJ, Schmitz J, The European SENTRY Participants (2001): Frequency of isolation and antimicrobial resistance of Gram-negative and Gram-positive bacteria from patients in intensive care units of 25 European university hospitals participating in the European arm of the SENTRY Antimicrobial Surveillance Program 1997–1998. Eur J Clin Microbiol Infect Dis 20: 617–625. [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Fridkin SK, Hill HA, Volkova NV (2002): The Intensive Care Antimicrobial Resistance Epidemiology (CARE) project hospitals. Temporal changes in prevalence of antimicrobial resistance in 23 U.S. hospitals. Emerg Infect Dis 8: 697–701. [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Garcia Navarro VM, Gonzales A, Fuentes M, Aviles M, Rios MY, Zepeda G, Rojas MG (2003): Antifungal activities of nine traditional Mexican medicinal plants. J Ethnopharma 87: 85–88. [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Hugh R, Ryschenkow E (1961): Pseudomonas maltophilia., an alcaligenes-like species. J Gen Microbiol 26: 123–132. [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Krueger TS, Clark EA, Nix DE (2001): In vitro susceptibility of Stenotrophomonas maltophilia. to various antimicrobial combinations. Diagn Microbiol Infect Dis 41: 71–78. [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Lesco-Bornet M, Bergogne-Berezin E (1997): Susceptibility of 100 strains of Stenotrophomonas maltophilia. to three betalactams and five beta-lactam-beta-lactamase inhibitor combinations. J Antimicrob Chemother 40: 717–720. [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Liu PL, Lau YJ, Hu BS, Shyr JM, Shi ZY, Tsai WS, Lin YH, Tsen CY (1995): Comparison of susceptibility to extended-spectrum β-lactam antibiotics and ciprofloxacin among gram-negative bacilli isolated from intensive care units. Diagn Microbiol Infect Dis 22: 285–291. [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Miller LA, Ratnam K, Payne DJ (2001): β-Lactamase-inhibitor combinations in the 21st century: Current agents and new developments. Curr Opin Pharmacol 1: 451–458. [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• NCCLS (1999): National Committee for Clinical Laboratory Standards: Performance standards for antimicrobial disk susceptibility tests, 9th ed. Villanova, PA, NCCLS.
   Google Scholar
• Palleroni NJ, Bradbury JF (1993): Stenothrophomonas., a new bacterial genus for Xanthomonas maltophilia. (Hugh 1980). Int J Syst Bacteriol 43: 606–609. [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Perez C, Agnese AM, Cabrera JL (1999): The essential oil of Senecio graveolens. (Compositae): Chemical composition and antimicrobial activity tests. J Ethnopharmacol 66: 91–96. [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Poulos CD, Matsumura SO, Willey BM, Low DE, McGeer A (1995): In vitro activities of antimicrobial combinations against Stenotrophomonas. (Xanthomonas.) maltophilia.. Antimicrob Agents Chemother 39: 2220–2223. [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Rojas R, Bustamante B, Bauer J, Fernendez I, Ablan J, Lock O (2003): Antimicrobial activity of selected Peruvian medicinal plants. J Ethnopharmacol 88: 199–204. [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Robin T, Janda JM (1996): Pseudo-, Xantho-, Stenotrophomas maltophilia.: An emerging pathogen in search of a genus. Clin Microbiol News 18: 9–13. [CROSSREF], [CSA]
   Google Scholar
• Skaehill P (2000): Clinical review. Management of Stenotrophomonas maltophilia. infections. The Consult Pharmacist 15: 74–76. [CSA]
   Google Scholar
• Swings J, De Vos P, Van den Mooter M, De Ley D (1983): Transfer of Pseudomonas maltophilia. (Hugh 1981) to the genus Xanthomonas maltophilia. (Hugh 1981) comb. nov. Int J Syst Bacteriol 33: 409–413. [CSA]
   Google Scholar
• Uzun E, Sarιyar G, Adsersen A, Karakoc B, Otuk G, Oktayoglu E, Pirildar S (2004): traditional medicine in Sakarya province (Turkey) and antimicrobial activities of selected species. J Ethnopharmacol 95: 287–296. [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Vartivarian S, Anaissie E, Bodey G, Sprigg H, Rolston K (1994): A changing pattern of susceptibility of Xanthomonas maltophilia. to antimicrobial agents: Implications for therapy. Antimicrob Agents Chemother 38: 624–627. [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Yamazaki E, Ishii J, Sato K, Nakae T (1989): The barrier function of the outer membrane of Pseudomonas maltophilia. in the diffusion of saccharides and β-lactam antibiotics. FEMS Microbiol Lett 60: 85–88. [CROSSREF], [CSA]
   Google Scholar